Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review
- PMID:25724076
- DOI: 10.1016/j.drugalcdep.2015.01.040
Treatment of toxicity from amphetamines, related derivatives, and analogues: a systematic clinical review
Abstract
Background: Overdose of amphetamine, related derivatives, and analogues (ARDA) continues to be a serious worldwide health problem. Patients frequently present to the hospital and require treatment for agitation, psychosis, and hyperadrenegic symptoms leading to pathologic sequelae and mortality.
Objective: To review the pharmacologic treatment of agitation, psychosis, and the hyperadrenergic state resulting from ARDA toxicity.
Methods: MEDLINE, PsycINFO, and the Cochrane Library were searched from inception to September 2014. Articles on pharmacologic treatment of ARDA-induced agitation, psychosis, and hyperadrenergic symptoms were selected. Evidence was graded using Oxford CEBM. Treatment recommendations were compared to current ACCF/AHA guidelines.
Results: The search resulted in 6082 articles with 81 eligible treatment involving 835 human subjects. There were 6 high-quality studies supporting the use of antipsychotics and benzodiazepines for control of agitation and psychosis. There were several case reports detailing the successful use of dexmedetomidine for this indication. There were 9 high-quality studies reporting the overall safety and efficacy of β-blockers for control of hypertension and tachycardia associated with ARDA. There were 3 high-quality studies of calcium channel blockers. There were 2 level I studies of α-blockers and a small number of case reports for nitric oxide-mediated vasodilators.
Conclusions: High-quality evidence for pharmacologic treatment of overdose from ARDA is limited but can help guide management of acute agitation, psychosis, tachycardia, and hypertension. The use of butyrophenone and later-generation antipsychotics, benzodiazepines, and β-blockers is recommended based on existing evidence. Future randomized prospective trials are needed to evaluate new agents and further define treatment of these patients.
Keywords: Agitation; Amphetamines; Beta-blockers; Hypertension; Sedation; Tachycardia.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
- Treatment of cocaine cardiovascular toxicity: a systematic review.Richards JR, Garber D, Laurin EG, Albertson TE, Derlet RW, Amsterdam EA, Olson KR, Ramoska EA, Lange RA.Richards JR, et al.Clin Toxicol (Phila). 2016 Jun;54(5):345-64. doi: 10.3109/15563650.2016.1142090. Epub 2016 Feb 26.Clin Toxicol (Phila). 2016.PMID:26919414Review.
- Psychosis induced by amphetamines.Bramness JG, Rognli EB.Bramness JG, et al.Curr Opin Psychiatry. 2016 Jul;29(4):236-41. doi: 10.1097/YCO.0000000000000254.Curr Opin Psychiatry. 2016.PMID:27175554Review.
- Treatment for amphetamine psychosis.Srisurapanont M, Kittiratanapaiboon P, Jarusuraisin N.Srisurapanont M, et al.Cochrane Database Syst Rev. 2001;(4):CD003026. doi: 10.1002/14651858.CD003026.Cochrane Database Syst Rev. 2001.Update in:Cochrane Database Syst Rev. 2008 Oct 08;(4):CD003026. doi: 10.1002/14651858.CD003026.pub2.PMID:11687172Updated.Review.
- Dexmedetomidine use in the ED for control of methamphetamine-induced agitation.Lam RPK, Yip WL, Wan CK, Tsui MSH.Lam RPK, et al.Am J Emerg Med. 2017 Apr;35(4):665.e1-665.e4. doi: 10.1016/j.ajem.2016.11.004. Epub 2016 Nov 3.Am J Emerg Med. 2017.PMID:27842924
- Suicidal attempt with caffeine overdose treated with dexmedetomidine: a case report.Kitano T, Okajima M, Sato K, Noda T, Taniguchi T.Kitano T, et al.J Med Case Rep. 2021 Jan 16;15(1):11. doi: 10.1186/s13256-020-02611-6.J Med Case Rep. 2021.PMID:33451341Free PMC article.
Cited by
- Avoidance of β-blockers in patients who use stimulants is not supported by good evidence.Wilson T, Pitcher I, Bach P.Wilson T, et al.CMAJ. 2022 Jan 31;194(4):E127-E128. doi: 10.1503/cmaj.211347.CMAJ. 2022.PMID:35101873Free PMC article.No abstract available.
- Self-discharge during treatment for acute recreational drug toxicity: an observational study from emergency departments in seven European countries.Vallersnes OM, Dines AM, Wood DM, Heyerdahl F, Hovda KE, Yates C, Giraudon I, Caganova B, Ceschi A, Galicia M, Liakoni E, Liechti ME, Miró Ò, Noseda R, Persett PS, Põld K, Schmid Y, Scholz I, Vigorita F, Dargan PI.Vallersnes OM, et al.Int J Emerg Med. 2023 Nov 29;16(1):86. doi: 10.1186/s12245-023-00566-1.Int J Emerg Med. 2023.PMID:38030969Free PMC article.
- Ziconotide-induced psychosis: A case report and literature review.Burdge G, Leach H, Walsh K.Burdge G, et al.Ment Health Clin. 2018 Aug 30;8(5):242-246. doi: 10.9740/mhc.2018.09.242. eCollection 2018 Sep.Ment Health Clin. 2018.PMID:30206508Free PMC article.
- Methamphetamine Toxicities and Clinical Management.Coffin PO, Suen LW.Coffin PO, et al.NEJM Evid. 2023 Dec;2(12):EVIDra2300160. doi: 10.1056/EVIDra2300160. Epub 2023 Nov 28.NEJM Evid. 2023.PMID:38320504Free PMC article.Review.
- A Sympathetic Treatment for Obesity.Kim JD, Diano S.Kim JD, et al.Cell Metab. 2020 Jun 2;31(6):1043-1045. doi: 10.1016/j.cmet.2020.05.009.Cell Metab. 2020.PMID:32492388Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Medical